Sangamo Biosciences (SGMO) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Financial Fact:
Total operating expenses: 22.03M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total operating expenses: 22.03M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Sangamo Biosciences (NASDAQ: SGMO) reported Q3 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $12.4 million versus the consensus estimate of $8.27 million.
Sangamo Biosciences sees FY2014 revenue of $45-50 million, versus the consensus of $47.57 million.
For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
